MENU
+Compare
MTEM
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$0.36
Change
-$0.00 (-0.00%)
Capitalization
2.34M

MTEM Molecular Templates Forecast, Technical & Fundamental Analysis

a developer of immunotoxins

Industry Biotechnology
MTEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for MTEM with price predictions
Dec 17, 2024

MTEM in +8.38% Uptrend, advancing for three consecutive days on December 10, 2024

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MTEM advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MTEM's RSI Indicator exited the oversold zone, of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 17, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on MTEM as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MTEM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MTEM broke above its upper Bollinger Band on December 05, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.330) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). MTEM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.085) is also within normal values, averaging (260.687).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MTEM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTEM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MTEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a developer of immunotoxins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9301 Amberglen Boulevard
Phone
+1 512 869-1555
Employees
62
Web
https://www.mtem.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKRO30.611.38
+4.72%
Akero Therapeutics
TAOP0.33N/A
-0.67%
Taoping
DRS34.44-0.24
-0.71%
Leonardo DRS
CPF30.22-0.68
-2.20%
Central Pacific Financial Corp
XNET2.07-0.09
-4.17%
Xunlei Limited

MTEM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MTEM has been loosely correlated with GOSS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MTEM jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTEM
1D Price
Change %
MTEM100%
-2.44%
GOSS - MTEM
39%
Loosely correlated
+1.71%
AXON - MTEM
36%
Loosely correlated
-2.09%
CYTK - MTEM
34%
Loosely correlated
-2.53%
ASND - MTEM
32%
Poorly correlated
+2.71%
INM - MTEM
31%
Poorly correlated
N/A
More